At BioCanRx, we work to advance cancer immunotherapies through the complex pathway from bench to bedside. Here, President and CEO Dr. Stéphanie Michaud explains the unique role our organization plays in funding and coordinating the research necessary to bring new therapies to Health Canada. Find out how BioCanRx uniquely supports cancer immunotherapy clinical trials across Canada—helping innovative treatments reach patients who need them. Spend a few minutes to learn more about BioCanRx, our raison d’etre, and our mission to launch more clinical trials and treat more patients with made-in-Canada innovations.